Instil Bio
NASDAQ: TILDallas, US · Founded 2018 · New York corporation · 2 known investors
Instil Bio is a biotechnology company that identifies and develops therapeutic opportunities, with a focus on cancer therapies. It operates in the biopharmaceutical industry, drawing on cell therapy and oncology expertise.
Biotechin /instil-bio
Founders & leadership
NS
Nimish ShahDirector
BC
Bronson CrouchChief Executive Officer & Chairman of the Board
JN
Jack NielsenDirector
GB
Gwen BinderDirector
KM
Kent McGaughyDirector
NG
Neil GibsonDirector
GM
George MatchamDirector
S"
Sandeep "Steve" LaumasChief Financial Officer & Chief Business Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$185.4MraisedFeb 2021 · 26 investors · BiotechnologyRule 506(b)
▶$185.4MraisedFeb 2021 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sandeep LaumasExecutive Officer
- Gwen BinderDirector
- Nimish ShahDirector
- Jack NielsenDirector
- Neil GibsonDirector
- Kent McGaughyDirector
- Bronson CrouchExecutive Officer, Director
- George MatchamDirector
- Offering amount
- $185.4M
- Amount sold
- $185.4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$25MraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$25MraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nimish ShahDirector
- Bronson CrouchExecutive Officer, Director
- Jack NielsenDirector
- Gwen BinderDirector
- Kent McGaughyDirector
- Neil GibsonDirector
- George MatchamDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$515.9KraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$515.9KraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George MatchamDirector
- Gwen BinderDirector
- Jack NielsenDirector
- Bronson CrouchExecutive Officer, Director
- Neil GibsonDirector
- Nimish ShahDirector
- Kent McGaughyDirector
- Offering amount
- $515.9K
- Amount sold
- $515.9K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$170.2MraisedAug 2020 · 15 investors · BiotechnologyRule 506(b)
▶$170.2MraisedAug 2020 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nimish ShahDirector
- Jack NielsenDirector
- Kent McGaughyDirector
- Neil GibsonDirector
- Gwen BinderDirector
- Bronson CrouchExecutive Officer, Director
- George MatchamDirector
- Offering amount
- $170.2M
- Amount sold
- $170.2M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.